Physician profile
Andrew Rosenthal
NPI 1356351076
$2,402.51
in general payments reported to CMS, 2019-2025
11 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $23.90 · 2021: $106 · 2022: $118 · 2023: $255 · 2024: $1,018 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,494.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $702.86 | 2022-2024 | Novosorb Btm |
| Merz North America, INC. | $495.88 | 2019 | |
| Atricure, INC. | $478.98 | 2024 | |
| Depuy Synthes Sales INC. | $351.51 | 2023-2025 | Na, Matrixrib |
| Allergan, INC. | $145.95 | 2019 | |
| Kls-Martin L.P. | $105.65 | 2021 | |
| Davol INC. | $48.77 | 2025 | Phasix Mesh |
| Organogenesis INC. | $23.90 | 2020 | |
| Avanos Medical | $18.80 | 2019 | |
| Avita Medical Americas, LLC | $16.37 | 2024 | |
| Teleflex LLC | $13.84 | 2023 | Quikclot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Rosenthal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.